8-K - BridgeBio Oncology Therapeutics Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 7, 2026, BridgeBio Oncology Therapeutics, Inc. (the “Company”) issued a press release titled “ BBOT Announces New Clinical Data Advanci

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated January 7, 2026. 104 Cover Page Interactive Data File (embedde

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1